HowardJeffreyWeinsteinMD

Pediatric Hematology & Oncology • Boston, MA

Chief, Peds Hem-Onc at MassGeneral Hosp. for Children

Join to view full profile

Dr. Weinstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Weinstein's full profile

Already have an account?

Office
55 Fruit St
Yaw 8B Pediatric Hematology Oncology
Boston, MA 02114
Phone+1 617-724-3315

Fax+1 617-724-8526

Summary

Dr. Howard Weinstein is a pediatric hematologist/oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Massachusetts General Hospital and Newton-Wellesley Hospital. He received his medical degree from University of Maryland School of Medicine and has been in practice 45 years. He is experienced in acute myeloid leukemia, hodgkin's lymphoma, pediatric non-hodgkin's lymphoma, healthcare outcomes research, and combined modality therapy.

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1975 - 1977
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1974 - 1975
Massachusetts General HospitalResidency, Pediatrics, 1972 - 1974
University of Maryland School of MedicineClass of 1972

Certifications & Licensure

MA State Medical License 1975 - 2025
MD State Medical License 1974 - 1991
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Boston Magazine Castle Connolly, 2008-2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Boston Herald Castle Connolly, 2005
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Start of enrollment: 2008 Feb 04
Active, not recruiting
Phase 3
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90.
Angela M Feraco, Yiwang Zhou, Ying Zheng, Lianna J Marks, Alison Friedmann
Blood Advances. 2023-11-14
12 citations
Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia.
Jonathan Paolino, Juliana Mariani, Alexandra Lucas, Jeremy Rupon, Howard J. Weinstein
Pediatric Blood & Cancer. 2019-07-01
19 citations
Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FA...
J. Kimble Frazer, Kevin J. Li, Paul J. Galardy, Sherrie L. Perkins, Anne Auperin
British Journal of Haematology. 2019-04-01

Press Mentions

Brookline Residents Inspired to Run Marathon for Mass. GeneralMarch 23rd, 2018
Weymouth Oncology Nurse Sets Sights on Boston MarathonApril 13th, 2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Other Languages

French